137 related articles for article (PubMed ID: 16900654)
1. [Application of imiquimod and resiquimod in dermatology].
Xu KJ; Liu YH
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Jun; 28(3):445-7. PubMed ID: 16900654
[TBL] [Abstract][Full Text] [Related]
2. Imiquimod; an international update on therapeutic uses in dermatology.
Tyring S; Conant M; Marini M; Van Der Meijden W; Washenik K
Int J Dermatol; 2002 Nov; 41(11):810-6. PubMed ID: 12453012
[TBL] [Abstract][Full Text] [Related]
3. Imiquimod (Aldara): modifying the immune response.
Rudy SJ
Dermatol Nurs; 2002 Aug; 14(4):268-70. PubMed ID: 12240505
[TBL] [Abstract][Full Text] [Related]
4. [Imiquimod--a substance with a broad working spectrum].
Oster-Schmidt C
J Dtsch Dermatol Ges; 2004 Oct; 2(10):821-2. PubMed ID: 16281584
[No Abstract] [Full Text] [Related]
5. The role of topical immune response modifiers in skin cancer.
Woodmansee C; Pillow J; Skinner RB
Drugs; 2006; 66(13):1657-64. PubMed ID: 16978032
[TBL] [Abstract][Full Text] [Related]
6. Imiquimod in dermatology: an overview.
Hanna E; Abadi R; Abbas O
Int J Dermatol; 2016 Aug; 55(8):831-44. PubMed ID: 27387373
[TBL] [Abstract][Full Text] [Related]
7. [New perspective in immunotherapy: local imiquimod treatment].
Kemény L; Nagy N
Orv Hetil; 2010 May; 151(19):774-83. PubMed ID: 20427260
[TBL] [Abstract][Full Text] [Related]
8. Imiquimod.
Garland SM
Curr Opin Infect Dis; 2003 Apr; 16(2):85-9. PubMed ID: 12734440
[TBL] [Abstract][Full Text] [Related]
9. The use of topical 5% imiquimod during pregnancy: a case series.
Einarson A; Costei A; Kalra S; Rouleau M; Koren G
Reprod Toxicol; 2006 Jan; 21(1):1-2. PubMed ID: 16039826
[No Abstract] [Full Text] [Related]
10. Successful treatment of perianal warts in a child with 5% imiquimod cream.
Gruber PC; Wilkinson J
J Dermatolog Treat; 2001 Dec; 12(4):215-7. PubMed ID: 12241631
[TBL] [Abstract][Full Text] [Related]
11. Recent therapeutic advances in dermatology.
Lipper GM; Arndt KA; Dover JS
JAMA; 2000 Jan; 283(2):175-7. PubMed ID: 10634322
[No Abstract] [Full Text] [Related]
12. Imiquimod (Aldara cream).
Buck HW
Infect Dis Obstet Gynecol; 1998; 6(2):49-51. PubMed ID: 9702584
[No Abstract] [Full Text] [Related]
13. Genital warts reduced with imiquimod.
AIDS Patient Care STDS; 1998 May; 12(5):409. PubMed ID: 11361984
[No Abstract] [Full Text] [Related]
14. Successful treatment of anal and perianal condyloma acuminata with imiquimod.
Tawada C; Oshitani Y; Kimura M; Seishima M
Acta Derm Venereol; 2014 Jan; 94(1):118-9. PubMed ID: 23824207
[No Abstract] [Full Text] [Related]
15. Imiquimod as an immune response modulator in infectious conditions.
Skinner RB
Postgrad Med; 2002 Dec; 112(6 Suppl Using):8-16. PubMed ID: 19667608
[TBL] [Abstract][Full Text] [Related]
16. Imiquimod: a potential role in dermatology?
Eedy DJ
Br J Dermatol; 2002 Jul; 147(1):1-6. PubMed ID: 12100177
[No Abstract] [Full Text] [Related]
17. Successful management of viral infections and other dermatoses with imiquimod 5% cream.
Berman B; Hengge U; Barton S
Acta Derm Venereol Suppl (Stockh); 2003 Sep; (214):12-7. PubMed ID: 14606277
[No Abstract] [Full Text] [Related]
18. Topical imiquimod.
Pearson GW; Langley RG
J Dermatolog Treat; 2001 Mar; 12(1):37-40. PubMed ID: 12171687
[TBL] [Abstract][Full Text] [Related]
19. [Imiquimod and resiquimod. The onset of a new pharmaco-therapeutic class?].
Chosidow O; Cribier B; Aractingi S
Ann Dermatol Venereol; 2003; 130(8-9 Pt 1):713-7. PubMed ID: 14576599
[No Abstract] [Full Text] [Related]
20. [Imiquimod--clinical efficacy].
Beutner KR
Ann Dermatol Venereol; 2000; 127(10 Suppl):3S19-3S21. PubMed ID: 11116859
[No Abstract] [Full Text] [Related]
[Next] [New Search]
